{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:24:13Z","timestamp":1790292253096,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1245\/s10434-024-15116-z","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T20:01:24Z","timestamp":1710014484000},"page":"4822-4829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma"],"prefix":"10.1245","volume":"31","author":[{"given":"Asato","family":"Hashinokuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saito","family":"Shunichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoto","family":"Matsudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Akamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikihiro","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"issue":"1","key":"15116_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"15116_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam SS, Vansteenkiste J, Planchard D, et al. Overall survival with Osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med. 2020;382(1):41\u201350.","journal-title":"N Engl J Med."},{"issue":"11","key":"15116_CR3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41571-018-0081-4","volume":"15","author":"G Recondo","year":"2018","unstructured":"Recondo G, Facchinetti F, Olaussen KA, et al. Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI? Nat Rev Clin Oncol. 2018;15(11):694\u2013708.","journal-title":"Nat Rev Clin Oncol."},{"issue":"19","key":"15116_CR4","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodriguez-Abreu D, Robinson AG, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016;375(19):1823\u201333.","journal-title":"N Engl J Med."},{"issue":"10066","key":"15116_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","volume":"389","author":"A Rittmeyer","year":"2017","unstructured":"Rittmeyer A, Barlesi F, Waterkamp D, et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet. 2017;389(10066):255\u201365.","journal-title":"Lancet."},{"issue":"2","key":"15116_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1871520621666210608095512","volume":"22","author":"BM Sahoo","year":"2022","unstructured":"Sahoo BM, Banik BK, Borah P, et al. Reactive oxygen species (ROS): Key components in cancer therapies. Anticancer Agents Med Chem. 2022;22(2):215\u201322.","journal-title":"Anticancer Agents Med Chem."},{"key":"15116_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2016.03.042","volume":"387","author":"S Prasad","year":"2017","unstructured":"Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95\u2013105.","journal-title":"Cancer Lett."},{"issue":"12","key":"15116_CR8","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863(12):2977\u201392.","journal-title":"Biochim Biophys Acta."},{"issue":"3","key":"15116_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","volume":"19","author":"T Ishimoto","year":"2011","unstructured":"Ishimoto T, Nagano O, Yae T, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell. 2011;19(3):387\u2013400.","journal-title":"Cancer Cell."},{"issue":"13","key":"15116_CR10","doi-asserted-by":"crossref","first-page":"117727191875539","DOI":"10.1177\/1177271918755391","volume":"6","author":"S Kumari","year":"2018","unstructured":"Kumari S, Badana AK, Malla R. Reactive oxygen species: a key constituent in cancer survival. Biomarker Insights. 2018;6(13):1177271918755391.","journal-title":"Biomarker Insights."},{"key":"15116_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2017.08.013","volume":"112","author":"B Griess","year":"2017","unstructured":"Griess B, Tom E, Domann F, et al. Extracellular superoxide dismutase and its role in cancer. Free Radic Biol Med. 2017;112:464\u201379.","journal-title":"Free Radic Biol Med."},{"key":"15116_CR12","doi-asserted-by":"publisher","first-page":"1147414","DOI":"10.3389\/fphar.2023.1147414","volume":"14","author":"J Pei","year":"2023","unstructured":"Pei J, Pan X, Wei G, et al. Research progress of glutathione peroxidase family (GPX) in redoxidation. Front Pharmacol. 2023;14:1147414.","journal-title":"Front Pharmacol."},{"issue":"6","key":"15116_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1165\/rcmb.2005-0325OC","volume":"35","author":"A Singh","year":"2006","unstructured":"Singh A, Rangasamy T, Thimmulappa RK, et al. Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am J Respir Cell Mol Biol. 2006;35(6):639\u201350.","journal-title":"Am J Respir Cell Mol Biol."},{"key":"15116_CR14","doi-asserted-by":"publisher","first-page":"2901840","DOI":"10.1155\/2019\/2901840","volume":"2019","author":"M Zalewska-Ziob","year":"2019","unstructured":"Zalewska-Ziob M, Adamek B, Kasperczyk J, et al. Activity of antioxidant enzymes in the tumor and adjacent noncancerous tissues of non-small-cell lung cancer. Oxid Med Cell Longev. 2019;2019:2901840.","journal-title":"Oxid Med Cell Longev."},{"key":"15116_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2022.06.232","volume":"188","author":"RS Esworthy","year":"2022","unstructured":"Esworthy RS, Doroshow JH, Chu FF. The beginning of GPX2 and 30 years later. Free Radic Biol Med. 2022;188:419\u201333.","journal-title":"Free Radic Biol Med."},{"key":"15116_CR16","doi-asserted-by":"publisher","first-page":"7370157","DOI":"10.1155\/2020\/7370157","volume":"2020","author":"H Du","year":"2020","unstructured":"Du H, Chen B, Jiao NL, et al. Elevated glutathione peroxidase 2 expression promotes cisplatin resistance in lung adenocarcinoma. Oxid Med Cell Longev. 2020;2020:7370157.","journal-title":"Oxid Med Cell Longev."},{"issue":"6","key":"15116_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1096\/fba.2022-00045","volume":"5","author":"F Peng","year":"2023","unstructured":"Peng F, Xu Q, Jing X, et al. GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K\/AKT\/mTOR\/Snail signaling axis. FASEB Bioadv. 2023;5(6):233\u201350.","journal-title":"FASEB Bioadv."},{"issue":"6","key":"15116_CR18","doi-asserted-by":"publisher","first-page":"101042831770041","DOI":"10.1177\/1010428317700410","volume":"39","author":"T Liu","year":"2017","unstructured":"Liu T, Kan XF, Ma C, et al. GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma. Tumour Biol. 2017;39(6):1010428317700410.","journal-title":"Tumour Biol."},{"issue":"3","key":"15116_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cllc.2011.03.012","volume":"12","author":"H Yang","year":"2011","unstructured":"Yang H, Wang W, Zhang Y, et al. The role of NF-E2-related factor 2 in predicting chemoresistance and prognosis in advanced non-small-cell lung cancer. Clin Lung Cancer. 2011;12(3):166\u201371.","journal-title":"Clin Lung Cancer."},{"issue":"11","key":"15116_CR20","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/cancers11111755","volume":"11","author":"AA Zimta","year":"2019","unstructured":"Zimta AA, Cenariu D, Irimie A, Magdo L, Nabavi SM, Atanasov AG, Berindan-Neagoe I. The role of Nrf2 activity in cancer development and progression. Cancers. 2019;11(11):1755.","journal-title":"Cancers."},{"issue":"6","key":"15116_CR21","doi-asserted-by":"publisher","first-page":"101042831770144","DOI":"10.1177\/1010428317701443","volume":"39","author":"D Liu","year":"2017","unstructured":"Liu D, Sun L, Tong J, et al. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma. Tumour Biol. 2017;39(6):1010428317701443.","journal-title":"Tumour Biol."},{"issue":"9","key":"15116_CR22","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/carcin\/bgu048","volume":"35","author":"T Naiki","year":"2014","unstructured":"Naiki T, Naiki-Ito A, Asamoto M, et al. GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer. Carcinogenesis. 2014;35(9):1962\u20137.","journal-title":"Carcinogenesis."},{"issue":"8","key":"15116_CR23","doi-asserted-by":"publisher","first-page":"e2107266119","DOI":"10.1073\/pnas.2107266119","volume":"119","author":"Z Ren","year":"2022","unstructured":"Ren Z, Liang H, Galbo PM Jr, et al. Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer. Proceed Nat Acad Sci. 2022;119(8):e2107266119.","journal-title":"Proceed Nat Acad Sci"},{"key":"15116_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12885-016-2462-3","volume":"16","author":"Z Lei","year":"2016","unstructured":"Lei Z, Tian D, Zhang C, et al. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma. BMC Cancer. 2016;16:410.","journal-title":"BMC Cancer."},{"issue":"11","key":"15116_CR25","doi-asserted-by":"publisher","first-page":"7780","DOI":"10.1002\/jcp.29391","volume":"235","author":"F Li","year":"2020","unstructured":"Li F, Dai L, Niu J. GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway. J Cell Physiol. 2020;235(11):7780\u201390.","journal-title":"J Cell Physiol."},{"issue":"24","key":"15116_CR26","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41388-023-02708-4","volume":"42","author":"H Xu","year":"2023","unstructured":"Xu H, Hu C, Wang Y, et al. Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism. Oncogene. 2023;42(24):1994\u20132006.","journal-title":"Oncogene."},{"issue":"10","key":"15116_CR27","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1158\/0008-5472.CAN-15-1584","volume":"76","author":"H Satoh","year":"2016","unstructured":"Satoh H, Moriguchi T, Saigusa D, et al. NRF2 intensifies host defense systems to prevent lung carcinogenesis, but after tumor initiation accelerates malignant cell growth. Cancer Res. 2016;76(10):3088\u201396.","journal-title":"Cancer Res."},{"issue":"21","key":"15116_CR28","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1158\/0008-5472.CAN-17-0449","volume":"77","author":"H Huang","year":"2017","unstructured":"Huang H, Zhang W, Pan Y, et al. YAP suppresses lung squamous cell carcinoma progression via deregulation of the DNp63-GPX2 axis and ROS accumulation. Cancer Res. 2017;77(21):5769\u201381.","journal-title":"Cancer Res."},{"issue":"6","key":"15116_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2022.8422","volume":"48","author":"M Wang","year":"2022","unstructured":"Wang M, Chen X, Fu G, et al. Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS-mutated lung cancer cells. Oncol Rep. 2022;48(6):1\u20134.","journal-title":"Oncol. Rep."},{"key":"15116_CR30","doi-asserted-by":"crossref","unstructured":"Ahmed KM, Veeramachaneni R, Deng D, et al. Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response. J Immunother Cancer. (2022);10(8)","DOI":"10.1136\/jitc-2022-004752"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15116-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T20:09:51Z","timestamp":1718050191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15116-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["15116"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15116-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,9]]},"assertion":[{"value":"13 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflicts of interest associated with this research. The graphical abstract has been designed using freely available resources from Flaticon.com.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}